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Abstract 
The media plays an important role in informing the public about medical 
and scientific research and discoveries. However little is know about how the 
media covers these topics and disseminates information to the public. For this 
paper, I examined the media coverage of a debate about the usefulness of 
screening mammography in preventing mortality from breast cancer. The 
controversy began in October of 2001 when two researchers, Olsen and 
G0tzsche, published a review for the Cochrane Collaboration in The Lancet, a 
prestigious British medical journal. In it they stated that according to their 
analysis mammography was not useful in preventing breast cancer mortality. 
To examine the debate that ensued after the article was published I went 
to three major types of sources. These three sources formed the three arms of 
my conceptual model. The first set of sources were the original letters, editorials 
and articles in published in The Lancet about the mammography issue between 
October of 2001 and March of 2002. The second set of sources were articles, 
editorials and stories from six major newspapers and five major television news 
sources published or broadcast about the controversy during the time frame of 
October 2001-March 2002. The last group of sources were the news releases 
and information of other major players such as the National Cancer Institute, 
United States Preventive Services Task Force and the American Cancer Society. 
My goal was to examine how the research community, the news media and the 
major players in the cancer field interacted to develop the debate. 
The story of the debate will be presented chronologically as events 
happened from the publishing of the original article in October 2001, to the 
statements by the major cancer organizations and several expert panels who 
revisited the issue in light of the controversy, then to the Senate hearings in 
February and concluding with the coverage another review of mammography 
published by The Lancet in March 2002. 
I conclude with a summary of the debate, the role of the media in 
covering the debate, and suggestions on how to handle these types public health 
and medical controversies in the future. 
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Acronyms Used in the Text: 
ACS -The American Cancer Society 
NCI- The National Cancer Institute 
NIH~ The National Institutes of Health 
NYT- The New York Times 
PDQ -The Physician Data Query Editorial Board 
US DHHS -'-The United States Department of Health and Human Services 
USPSTF- The United States Preventive Services Task Force 
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Section 1 - Introduction 
A controversial research letter published in The Lancet in the fall of 2001 
sparked a debate over the value of mammography in preventing breast cancer 
mortality. For many years the public and medical professionals have been told 
the same thing - Regular screening mammography detects breast cancer early 
and prevents deaths from breast cancer in women who are screened (American 
Cancer Society 2002, US Preventive Services Task Force 1995, 2002). These 
conclusions came from evidence from randomized clinical trials. In these trials 
screening mammography was shown to be an efficacious method of reducing 
breast cancer mortality. These trials have found that breast cancer can be 
~ detected in earlier and more treatable stages using mammography (Fletcher SW 
et al. 1993, Kerlikowske Ketal. 1995, Kattlove H et al. 1995, Chen HH et al. 
1995, Tabar L et al. 1995, Tabar L et al. 1999). These conclusions led many 
organizations to recommend mammography for all women beginning at age 40 
or 50 on an annual or semi-annual basis (American Cancer Society 2002, 
National Cancer Institute 2002). However in October 2001 the conclusions about 
the benefits of screening mammography were called into question when two 
researchers reanalyzed the seven major randomized clinical trials of 
mammography for the prestigious Cochrane Collaboration and came to a 
conclusion that went against most previous consensus about mammography 
(Olsen and Gotzsche 2001). They presented their data in a research letter in 
which they made the following statement. 
5 Randolph 
"There is no reliable evidence that screening for breast cancer reduces mortality." 
-Ole Olsen and Peter C. Gllltzsche in The Lancet 2001 
The debate that has ensued since this publication has questioned many 
aspects of the value of mammography screening in a healthy population. Much 
of the debate in the scientific community disputing different aspects of Olsen and 
G0tzsche's review has taken place in the pages of that same journal. Important 
groups that make recommendations about screening to the public such as the 
National Cancer Institute, the US Department of Health and Human Services and 
the United States Preventive Services Task Force have reanalyzed their stances 
on screening and released statements to the press and public with their 
recommendations (NCI 2002, USDHHS 2002, USPSTF 2002). Even the United 
States Senate has conducted hearings on the mammography question 
(Congressional Record 2002). All this controversy has brought into question 
recommendations that have been made for many years about screening 
mammography. Of interest in this paper is the debate that arose recently about 
the use of screening mammography for detecting breast cancer- how it was 
handled in the scientific literature, how important entities such as the National 
Cancer Institute participated in the controversy and how the news media covered 
the events since this is how the public would access this information. 
Project Objectives 
For the purposes of this project I will examine the news coverage of the 
mammography controversy that began with Olsen and G0tzsche's research letter 
published in October of 2001 and died down again in March of 2002 when a 
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formal study rebutting the original article was published. I will look at the media 
sources that originally took up the story and focus in on the major sources of 
news in this country -selected television networks with a nationwide audience 
and a selection of major newspapers articles. Several sources of original 
information on this topic will also be examined including government entities such 
as the National Cancer Institute (NCI) and United States Senate, review panels 
such as the Physician Data Query (PDQ) and U.S. Preventive Services Task 
Force (USPSTF) and advocacy groups such as the American Cancer Society 
(ACS). 
My interest in this paper is how news media, scientific community and 
other major players interacted to influence each other and how these interactions 
and actions were represented to the public by news media. The print and 
broadcast media produced stories conveying information about the scientific 
debate in research community. They have also produced stories and editorials 
that have attempted to reassure women who rely on mammography as their only 
defense against their fear of breast cancer. Finally they have reported the 
activities of the various government bodies that reevaluated their stances on 
mammography screening and conveyed their recommendations to the public. 
This interaction is the basis of the conceptual model in this paper. I will attempt 
to show how each factor influenced the other to produce the news coverage seen 
by the public. 
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Research Questions and Specific Aims 
In this paper I will examine how one issue (doubts about the usefulness of 
screening mammography) created a debate that raged for months. The initial 
question was, what started the debate? How did one research letter spark such 
controversy that the media and other important entities interacted for months 
responding to it? Therefore to start off, a section about screening mammography 
in general and the Olsen and G0tzsche's review in particular are included to help 
contextualize the debate. Then I will examine the events of the debate and the 
media coverage chronologically - who first picked up the story in the press, what 
sources picked it up next and what media sources covered it? As part of this 
chronology I will more closely examine the actions of the major players -what 
things did they do and how were their actions reported by the press? Finally I will 
offer some hypotheses about what messages were received by the public about 
screening mammography and will attempt to offer some insight into how this 
debate serves as an important model of how the media, medical and public 
health research community and other organizations act together to inform the 
public about important health issues. 
Question 1 -What started the debate? 
For the first question I looked at the original Olsen and G0tzsche's review 
and the Lancet published editorials and correspondence addressing it. Of interest 
was the content of this literature and what the media picked up on. 
Specific Aim 1: To assess the content of the original research letter that declared 
screening mammography ineffective and the scientific communities response. 
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Question 2- Who first picked up the story in the press? What was the timeline 
after the original article? What sources covered it the most? 
For the second question I was interested in how this particular article 
jumped from the scientific literature to mass media attention. When did the 
media take notice and which sources produced the original articles? Additionally 
what events sparked further coverage? 
Specific Aim 2: To locate media coverage through systematic search of major 
newspaper articles and television transcripts to determine patterns of coverage 
by the sources and form tallies to determine which sources covered the issues 
and when. 
Question 3- What was the content of the newspaper articles and television 
stories? How did their content reflect what was going on in the scientific 
literature? 
These questions will be answered in the course of the paper by reporting 
on actions of different entities and what the press wrote or said about them. 
Specific Aim 3: To chronologically report on the coverage by the press over the 
months from October 2001 until March 2002. 
Question 4- How did outside forces (the Senate, NCI, etc.) influence what was 
said in the press? What actions did they take in response to the debate? 
To address this question each entity will be researched to determine any 
actions they took in response to the debate and then what the press covered 
about them. 
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Specific Aim 4: To examine the actions of important players such as the National 
Cancer Institute. United States Senate, United States Department of Health and 
Human Services and the American Cancer Society to determine what they did 
and how the media covered it. 
Question 5- What was the final message to the public? Did anything really 
change? What can we learn for future controversies? 
For this question I was interested in what really ended up changing after 
all this occurred. Were women confused- or did they even follow what was 
going on? 
Specific Aim 5: To locate and report on the final statements from the major 
players and to investigate what the public understood about the debate. 
Conceptual Model 
For this paper I am examining the debate about the value of 
mammographic screening that arose in the fall of 2001. When Olsen and 
G0tzsche's Cochrane review was published it was the first article in a long time 
to challenge the commonly held belief that mammography was an effective 
screening tool for detecting breast cancer in women. This one research letter 
started a significant discussion into the value of screening for all women. Some 
of this debate was conveyed to the public by the press in the form of articles in 
newspapers and stories on television news. Other players in the debate 
including government health agencies, advocacy groups and research review 
bodies also had their actions and recommendations reported on by the press. 
Information in The Lancet may have begun the debate, but over the next few 
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months the media received information about screening mammography from 
many different sides. Individual scientists and physicians wrote editorials and 
gave interviews to reporters, and scientific institutions and government agencies 
discussed the topic and issued their own statements and released 
recommendations to the press about screening mammography. Other research 
about media effects has shown that most likely the major players in this debate 
were not immune to the information coming from the press and were most likely 
either driven to action by it or influenced by its coverage (Jasperson AE et al. 
1998). Therefore in the model the actions of each entity were theoretically 
influenced by the actions of every other entity and influenced by them. 
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The Lancet 
In this paper, I marked the start of the debate covered with the research 
letter authored by Olsen and G0tzsche and published in The Lancet, an 
important medical journal considered to be a leading sources of medical research 
in the world, stating that a review of the randomized controlled trials showed no 
benefit to screening mammography (Olsen and G0tzsche 2001). Accompanying 
the initial letter was an editorial and over the next few months letters and 
editorials from many different researchers from around the world were published 
in its pages. In March of 2002, a group of Swedish researchers published an 
article reviewing the benefits of Swedish randomized controlled trials of 
mammography which said that mammography was as useful as originally 
thought (Nystrom Let al. 2002). This seemed to bring closure to the debate for 
now. The research published in the Lancet influenced both the media and the 
other major players outlined in the conceptual model. The media, both television 
and print, reported on the different findings published in the journal. Other major 
players such as the National Cancer Institute, the U.S. Senate and the US 
Preventive Services Task Force looked at the information published by the 
Lancet regarding the issue when reviewing and forming their recommendations 
about mammography. While not all of the inter-workings and letters published in 
the Lancet were ever reported on by the media or examined by the government 
players, the information published by the journal served as both a beginning and 
ending point in examining the controversy. 
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The Media 
The media is the second component of the conceptual model and in this 
case consists of 6 major newspapers and 5 television news networks. 
Theoretically I assume here that the media plays a major role in informing the 
general public about discoveries published in the scientific and medical research 
literature. Most individuals will never read The Lancet or The New England 
Journal of Medicine, therefore their knowledge of happenings in science and 
medicine will most likely be tied to their consumption of mass media sources. 
Some journals, in an attempt to facilitate dissemination of a new discovery will 
distribute information in the form of press releases that simplify the content of the 
major articles or major articles are distributed with an embargo on their 
publication date so that reporters will have an opportunity to prepare their stories 
before publication of the actual article. Similarly major policy making 
organizations such as the Department of Health and Human Services or the 
National Cancer Institute will hold press conferences or distribute press releases 
to facilitate media in covering important topics. 
In this case I was looking at coverage by newspapers and television news. 
The Pew Research Center Media Consumption Survey in 2000 found that 46% 
of people polled reported regularly reading the newspaper. Thirty percent 
reported watching the nightly network news regularly, 20% watched morning 
network news, 21% watched CNN regularly and 17% watched Fox News (2000). 
A higher percentage of women than men watched nightly network news regularly 
and a higher percentage of people aged 50-64 watched it regularly (Pew 
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Research Center 2000). A report specifically detailing how Americans follow 
scientific and medical news found that most say they either pay a "moderate 
amount" (50%) or a "great deal" of attention to this type of news (The National 
Health Council 1997). This same report found that more women then men follow 
health and science news (80% vs. 70%) and more people aged 50 or older 
(81 %) vs. those aged 18-29 (60%) followed it (The National Health Council 
1997). Therefore I concluded that a significant number of the public was 
following the media coverage of the mammography debate. · 
Other Major Players 
After the debate began in the pages of the Lancet and was picked up by 
the press, many different organizations joined the fray. These players included 
government agencies such as the National Cancer Institute and the United 
States Department of Health and Human Services, independent review boards 
like the Physician Data Query Panel and the U.S. Preventive Services Task 
Force, two United States Senate subcommittees and advocacy groups like the 
National Breast Cancer Coalition and the American Cancer Society. Between 
October 2001 and March 2002, each of these major players responded in some 
way to the debate. They held press conferences or issued statements to the 
press. Individual members were quoted by newspaper articles and interviewed 
for stories both on television and in the papers. So the major players in many 
ways tie the conceptual model together. They most likely read and were 
influenced both by the research in the Lancet and coverage of events by the 
• 
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media, and their actions and responses created more opportunities for media 
coverage or debate by the scientific community. 
However to understand this most recent debate about screening 
mammography it is necessary to start with a brief summary about mammography 
and reflect on the evidence for it and on some of the drawbacks and controversy 
about it. 
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Section 2 - Background on Screening Mammography 
Breast Cancer and Mammography 
In the U.S. breast cancer is the most common type of cancer in women 
and is the second leading cause of cancer-related death in women (American 
Cancer Society 2002, Reis LAG et al. 1999). Screening mammography is 
capable of detecting cancers at much earlier stages before they can be detected 
through physical exam or before physical symptoms have developed (ACS 
2002). Because breast cancer is a progressive disease, in theory screening is 
able to reduce breast cancer mortality by detecting tumors at smaller sizes, when 
the probability of lymph node metastases is lower, and by reducing the 
opportunity for the worsening of the grade of malignancy of the tumor (Tabar Let 
al. 1999, Tabar Let al. 1992). 
Prior Information from Clinical Trials and Other Studies of Mammography 
Efficacy and Effectiveness 
Screening mammography has been found to significantly reduce breast 
cancer mortality in clinical trials of women aged 50-69, and appears to be 
relatively cost-effective in this group (Fletcher SW et al. 1993, Eddy OM 1989, 
Chen HH et al. 1995, Kerlikowske Ketal. 1995, Larsson LG et al. 1996, Tabar L 
et al. 1999, Kattlove H et al. 1995). Therefore many major organizations 
recommend mammography for women in this age group (ACS 2000, USPSTF 
1995, 2000, NCI 2002). However scientists have previously debated about the 
evidence of using mammography in women older and younger than the 50-69 
year old age group (Begley 2002). For example, there is less evidence that 
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mammography is effective in women ages 40-49 and this resulted in a 
controversy over recommending it to this age group in 1997 (Begley 2002). In 
this case an NCI panel concluded that it was not useful for these women and 
they would not recommend it but in the end they were overruled by a mandate 
from the United States Senate (Begley 2002, Congressional Record 2002). 
There is a limited amount of clinical research including women over 70; therefore, 
the efficacy of mammography in women 70 and older is not clearly established 
(Fletcher SW et al. 1993, Kerlikowske Ketal. 1995, U.S. Preventive Services 
Task Force 1995). Data from the Swedish Two-County Trial has suggested 
screening mammography appears to reduce mortality up to age 74 with a 34% 
reduction in mortality for women 50-74, but no clinical trial studies have reported 
data on women 75 and older (Tabar Let al. 1995, Chen HH et al. 1995, 
Kerlikowske K et al. 1995). Therefore few organizations make clear 
recommendations about the use of mammography in this group of older women. 
Potential Drawbacks of Screening Mammography 
On the surface mammography appears to be a benign procedure, free 
from risks besides the immediate discomfort of the procedure itself. However in 
theory the beneficial aspects should outweigh the harms since mammography 
helps to detect cancers at smaller sizes than clinical breast exam alone. Harms 
due to mammography do exist and the primary harm is the risk of a false positive 
test. A false-positive finding leads to follow-up testing that has costs- physical, 
mental and financial. Mammograms can also be negative when a cancer really is 
present and may not show that a cancer is growing, giving a woman a false 
18 Randolph 
sense of security that she is free of breast cancer. For example, mammography 
has been shown to cause significant morbidity in the elderly due to false positive 
mammograms (Welch HG & Fisher ES 1998, Elmore JG et al. 1998, Kerlikowske 
Ketal. 1993). Therefore, balanced against the benefits of mammography are the 
costs, morbidity and adverse psychological effects of false positives (Eddy DM 
1989). Data on screening mammography finds that the sensitivity of 
mammography is around 90% and the false positive rate in the 2 to 4% range 
(Mushlin AI et al. 1998). Additionally mammography is best suited to detect 
about 15 to 20 percent of all breast cancers, the tumors that grow fast enough to 
be detected but also grow slow enough that they are not out of control 
(metastasized throughout the body) by the time they are seen (Begley S 2002). 
That may mean that 80% of breast cancers may not be helped with regular 
mammography. There is even evidence of possible increased unnecessary 
surgery resulting from mammography and increased detection of carcinoma in 
situ lesions which may never become invasive cancer (Olsen and G0tzsche 
2001 ). 
Controversies about Mammography 
Screening mammography has previously been controversial, but this 
most recent debate became high profile and garnered both media coverage and 
responses from government agencies and cancer organizations. 
This most recent controversy has focused on the value of mammography 
for screening on a population basis. There have been several previous debates 
about mammography mainly dealing with the appropriate age to begin screening. 
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In February of 1993 the National Cancer Institute convened an international 
panel to review the studies of mammography in order to revise 
recommendations. They end up withdrawing their previous guidelines and 
rewriting thern to exclude the recommendation of screening for women aged 40-
49 (NCI1993). In January 1997, a National Institutes of Health Consensus Panel 
reaffirms the lack of evidence for screening women aged 40-49 years (National 
Institutes of Health Consensus Development Panel1997). Congress intervened 
and pressured them into including this age group (40-49 year-olds) in their 
recommendations for annual mammography (Congressional Record 2002). 
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Section 3 - Methods 
Before beginning the project and forming the research questions, it was 
necessary to define the time period under examination. Obviously the beginning 
of the current debate was the publication of the Cochrane review on screening 
with mammography with breast cancer by the Danish researchers, Olsen and 
G0tzsche, in The Lancet (2001 ). To provide a easily identifiable end point the 
publication of an article in the Lancet in March of 2002, an updated overview of 
the Swedish randomized controlled trials of mammography which reaffirmed a 
benefit of reduced breast cancer mortality for women who were screened was 
chosen as the endpoint (Nystrom et al. 2002). This time period incorporated all 
of the correspondence, editorials and research letters published in The Lancet, 
the review by the Physician Data Query Panel, the statements put out by the 
National Cancer Institute and the Department of Health and Human Services, the 
new guidelines published by the U.S. Preventive Services Task Force, and the 
hearings on mammography conducted by several sub-committees of the U.S. 
Senate. 
Medical Literature 
Using Medline, I obtained the complete set of articles, letters and editorials 
about screening mammography that appeared in The Lancet from October 2001 
to March 2002. This was done by looking at the table of contents from every 
issue of The Lancet during the above defined time period and selecting the 
articles, letters and editorials related to the controversy. 
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Media 
To gather information about media coverage, I used the online database 
Lexis-Nexis to examine articles from newspapers and transcripts of television 
news coverage. Using Lexis-Nexis, I started with a key word search for 
mammograms in the title and text for the time period 10/01/01 -03/31/02 for 
major newspapers and then eliminated down to articles from USA Today, The 
New York Times, The Washington Post, Los Angeles Times, The Boston Globe 
and The Seattle Times. These papers were chosen for several reasons. All had 
at least one original article about the mammography debate specifically and most 
had more than one. Then the major newspapers with significant circulation either 
nationwide or in their area were chosen as these articles are either seen by a 
large number of people directly or when they are republished in their local 
papers. For example we chose USA Today even though it only had one article 
because it has the highest circulation in the United States. Four of the six 
newspapers chosen -the LA Times, New York Times, USA Today and 
Washington Post are four of the top five newspapers in circulation and therefore 
important and widely read sources of coverage (http://www.naa.org/) . The 
remaining source, the Wall Street Journal, is only included in the database Lexis-
Nexis in abstract form. The first two papers chosen the NYT and the Washington 
Post are also considered to be elite papers that are read by certain audiences 
and often set the tone for small papers reporting. The final two papers the 
Boston Globe and Seattle Times were added for regional variation. Additional 
reasons for inclusion for each paper are detailed below. The New York Times 
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was chosen not only because of its' nationwide readership, but because it is 
considered by other journalists to be one of the leading papers in the country and 
articles from it are often recycled to smaller papers. The Washington Post was 
chosen primarily because it was the first major newspaper to report on the 
Cochrane review and secondarily because the paper's continuing coverage of 
the debate over the time period and large readership. The Washington Post is 
also a major source of information for people inside "the Beltway", those in the 
government. The Boston Globe, located in the city with such significant medical 
institutions such as the Harvard Schools of Medicine and Public Health, the 
Massachusetts General Hospital and Brigham and Women's hospital was 
chosen for both its location and provocative editorials. The Seattle Times and 
the Los Angeles Times were chosen since they represented both West Coast 
readership and had some interesting original articles about the debate. By 
limiting to these 6 major newspapers this yielded about 100 articles with the 
keyword mammogram in the title or text. Since some important articles that were 
referenced by other articles were still missing I repeated the procedure of 
searching for articles using the keyword mammography in either the text or title 
and found approximately 10 additional articles and editorials. After going through 
the articles individually and reading for content I was able to eliminate articles not 
mentioning the controversy, letters to the editors (but not editorials) and 
correction notations. After doing this thirty-three articles and sixteen editorials 
remained, and this should represent a good sample of the coverage that the 
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public was exposed to while maximizing diversity of writing and editorialists. 
Table One summarizes the number of articles or editorials by newspaper source. 
Table One- Articles or Editorials Published in Selected Major Newspapers, 
October 2001-March 2002 
Newspaper Boston L.A. New York Seattle USA Washington 
Globe Times Times Times Today Post 
News Articles 2 3 17 1 1 9 
Editorials 2 3 6 3 0 2 
Total 4 6 23 4 1 11 
A priori I was able to choose the television news sources I wanted to use 
for the analysis. I chose to use all three major network news sources (ABC, NBC 
and CBS) since the public can usually receive these free of charge and all have 
morning and evening news coverage. Fifty-one percent of persons polled in the 
Pew Research Survey reported regularly watching some type of broadcast 
network news (2000). Since 40% of the persons surveyed also reported regular 
viewership of cable news such as CNN and Fox News, they are both included 
here (2000 ). 
To locate TV news transcripts, Lexis-Nexis transcript search was used. 
Each source (CBS, CNN, ABC, NBC and Fox News) was first searched with the 
keyword mammogram and then with the keyword mammography. After 
eliminating stories that were broadcast more than once and transcripts that were 
just mentions of mammography or mammograms in headlines, this yielded 
twenty-two unique stories on the topic of screening mammography. Table 2 
summarizes the number of stories by each broadcast source. Appendix A details 
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the number of articles and editorials published or broadcast by each source by 
week. 
Table Two- Stories broadcast on selected major television news sources 
concerning the debate over mammography. October 2001 -March 2002 
1 Television ABC CBS CNN Fox News NBC 
1 News Source 
3 5 8 1 5 
Internet 
Other sources of information were gathered from the Internet. To help 
assess how much the public was following the debate, the Kaiser/HaNard School 
of Public Health- Health News Index (www.kff.org) was examined for that six-
month period and it was found that people were polled concerning the 
mammogram issue for the period February 25, 2002- March 25, 2002. These 
survey questions and results were downloaded from the site. To look at the 
actions of the major players the websites for the Physician Data Query 
(www.cancer.gov), the American Cancer Society (www.cancer.org) and the U.S. 
Preventive SeNices Task Force (www.ahcpr.gov) were searched for reviews, 
statements or articles regarding the debates. In addition to this information, 
press releases and transcripts of press conferences were downloaded from the 
National Cancer Institute (www.cancer.gov) and the US Department of Health 
and Human SeNices ( www.hhs.gov/news/press/2002pres/20020221.html). Also 
found on the Internet was information from advocacy groups such as the National 
Breast Cancer Coalition (http://www.natlbcc.org/bin/index.htm). Finally the full 
Senate subcommittee transcript for the mammography hearing was obtained 
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using Lexis-Nexis database and a press release regarding the hearings was 
downloaded from Senator Barbara Mikulski's (D-MD) website 
(http:/ /mikulski .senate .qov/-miku lski/press/02/02/2002308431 .html ). 
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Section 4- Results -Chronology of the Debate 
Value of Mammography Questioned by Cochrane Review (October 2001) 
Introduction 
In the October 20, 2001 issue of the journal Lancet, a research letter 
stated that because mammography studies in the past were of mostly poor 
quality there was not enough data to show that screening mammography is 
effective in reducing mortality from breast cancer. In the version of their finding 
that Olsen and G0tzsche submitted to the Lancet, they stated that there was no 
reliable evidence that screening for breast cancer reduces mortality (Olsen and 
G0tzsche 2001). The two Danish researchers who authored the letter were 
originally writing a review for the prestigious Cochrane Collaboration, but due to 
conflicts with the Cochrane editors chose to publish a separate version research 
letter form to Lancet and in its unedited full form on the website at 
www.lancet.com. There was a great deal of controversy surrounding this action 
because the Cochrane editors had changed some of the systematic review in the 
final form published in electronic form in The Cochrane Database of Systematic 
Reviews and later in the Cochrane Library, the official source of Cochrane 
reviews (Horton 2001 ). The editors didn't agree with the some of the conclusions 
about mammography and possible unnecessary treatment reached by Olsen and 
G0tzsche and made the following statement in the Cochrane Library Document. 
"At this stage the editorial group has elected to publish the review of 
outcomes on mortality and breast-cancer mortality but defer presentation or 
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discussion of results on changes in treatment (mastectomy, radiotheraphy, etc.) 
until further editorial review has been completed." 
-The Cochrane Editors 2002 (In Olsen and 
G0tzsche's Cochrane Library Review) 
The majority of the editorial group did decide that because Olsen and 
G0tzsche has been conscientious in their efforts and had followed the agreed 
upon protocol that the sections of the review not having to do with treatment but 
with mammography screening itself should be published at that time (Olsen and 
G0tzsche 2002). They do state that despite it being published it did not mean 
that the editors necessarily agreed or disagreed with the conclusions reached by 
Olsen and G0tzsche. The editors did acknowledge that the conclusions of the 
review would most likely have implications for screening programs and that 
would possibly be controversial (Olsen and G0tzsche 2002). 
The actions of the editors have brought up accusations about their 
attempts to muzzle unpopular findings about mammography (Horton 2001 ). 
Despite the controversy over the way the findings were published and issues 
about treatment, the main focus of concern and controversy, as predicted by the 
Cochrane editors, has been about the conclusions about mammographic 
screening reached by the Danes. 
The Cochrane Collaboration 
The Cochrane Collaboration is an international group of researchers and 
others dedicated to systematic reviews of scientific evidence. The goal of the 
collaboration is to produce systematic, current reviews of randomized clinical 
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trials of health care to help health care practitioners in making informed decisions 
for their patients (The Cochrane Collaboration 2001 ). A quote from the front of 
their brochure summarizes their goals quite well. 
"Preparing, maintaining and promoting the accessibility of systematic 
reviews of the effects of health intervention." 
From The Cochrane Collaboration brochure 
Their goal is to facilitate systematic review and they standardize the 
criteria on how to perform the analyses in order to standardize the reports. 
International collaborative review groups consisting of researchers, health care 
professionals, consumers and others work together to generate reviews 
according to the criteria. The preparation and maintenance of the reviews are the 
responsibility of the group to which they are assigned and the groups work in 
consultation with the staff from the Cochrane Centres to produce them. The 
reviews are then reviewed by the editors and published electronically in The 
Cochrane Database of Systematic Reviews that are in the Cochrane Library. 
Cochrane reviews are systematic reviews and follow specific criteria. 
Olsen and G0tzsche followed these criteria in producing their review of 
randomized controlled trials of mammography (The Cochrane Collaboration 
2001 ). A systematic review begins with a clear statement of the objectives of the 
review and an outlining of the criteria that makes a trial eligible for inclusion. 
Then there is an exhaustive search for studies that meet the eligibility criteria. 
Once located the characteristics of each study are tabulated and the quality of 
the methods in the study assessed. After applying the eligibility criteria studies 
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that don't meet them can be excluded with appropriate justification. Ideally, the 
original investigators are involved in the next step; that is assembling the most 
complete set of data. The results of the studies are analyzed and if possible 
statistical analysis applied. Also if possible sensitivity and subgroup analyses are 
performed. Finally a structured report is composed and submitted for review 
(The Cochrane Collaboration 2001 ). 
Analysis of the Trials for the Review 
Olsen and G0tzsche's review was based on 7 randomized clinical trials of 
mammography screening conducted in the U.S., Canada and Europe. Both 
Olsen and G0tzsche's review and the review in the Cochrane Library despite 
their slightly differing conclusions included the same trials and analysis. The 
included trials were all randomized controlled trials comparing screening with 
mammography with no screening. These seven studies were chosen after an 
extensive literature review that included Medline searches, contacting 
researchers directly and looking at unpublished data when necessary. The seven 
trials were chosen based on the methodology of the trials. The trials used in the 
analysis are listed in Table 3 .. 
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Table 3- Randomized Clinical Trials of Screening Mammography Included in the 
Cochrane Review by Olsen and G0tzsche 
Study Quality Rating by Olsen and G0tzsche 
Canada 1980 a, b Medium 
Edinburgh 1978 Flawed 
Goteborg 1982 a, b Poor 
Malmo1976 Medium 
New York 1963 Flawed 
Stockholm 1981 Poor 
Two-County (Sweden) 1977 Poor 
According to the systematic review there were no trials of high quality, two 
of medium quality, three of poor quality and two were so flawed they had to be 
thrown out of the summary estimates. Considering only the trials of best quality, 
there was no affect of screening in deaths due to cancer. For example the two 
best trials (according to their criteria) failed to find an effect on breast cancer 
mortality (relative risk 0.97 Cl [0.82-1.14]) after 13 years of follow up. However 
when pooling the three trials of "poor-quality" trials there was marked effect (0.68 
[0.58-0.78]) of screening (Olsen and G0tzsche 2001 ). 
Conclusions of Olsen and G0tzsche's Review 
The researchers state that given the evidence of mammography screening 
trials they hope that women, clinicians and policy-makers consider the findings of 
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the review when deciding whether or not to get screening or to support screening 
programs (Olsen and G0tzsche 2001 ). They further state that it would be 
necessary to have another large, well-conducted trial using the current higher 
quality mammography technology and using all-cause mortality and not breast 
cancer mortality as the endpoint to determine if screening mammography is a 
useful technique in preventing breast cancer deaths (Olsen and G0tzsche 2001). 
The Medical Research Community Response in The Lancet (October 2001 
and December 2001) 
Correspondence and Commentaries about the Mammography Issue 
The commentary accompanying Olsen and G0tzsche's original research 
letter was entitled, "Screening mammography- an overview revisited" by Richard 
Horton was squarely on the side of the Danish researchers (2001 ). In his 
commentary Horton detailed the actions of the Cochrane reviewers in attempting 
to interfere with the results generated by Olsen and G0tzsche. He mentioned the 
need for full independent review of mammography using the individual patient 
data from each trial but noted that may be impossible since it would require the 
participation of each trial's principal investigator (Horton 2001). He finishes his 
commentary by stating that he agrees there is no reliable evidence from 
randomized trials to support population based screening mammography (Horton 
2001 ). 
A large portion of the correspondence section in the December 22/29, 
2001 issue of the Lancet was devoted to the screening debate. There was a 
section of letters entitled "Screening for breast cancer with mammography" that 
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were from different researchers from around the world. For example, Dr. 
Anthony Miller wrote in to support the results from the Health Insurance Plan 
(HIP) trial conducted in the U.S., which were dismissed by Olsen and G0tzsche 
as flawed (Miller 2001 ). Others wrote in to criticize different aspects of Olsen and 
G0tzsche methodology as flawed or inappropriate (Lee and Zuckerman 2001, 
Senn 2001 ). Some criticized the way they had gone about publishing their 
results (Duffy, Tabar and Smith 2001 ). While others added their support to the 
idea that screening on a population basis may not be appropriate given the types 
of cancers detected with mammography, the risks of false positives or costs to 
individual women or warning that opposition to the ideas may be due to personal 
or financial stake in screening (Thornton 2001, Vaidya 2001, Dixon-Woods et al. 
2001 ). Finally some warned that those opposed to the idea that screening is not 
effective may be those with a personal or financial stake in the mammography 
screening industry (Vaidya 2001 ). G0tzsche had the opportunity to respond to 
each letter and did so in his author's reply (2001 ). 
The Media Get Involved (October 2001 and December 2001) 
The Lone Ranger 
In the media sources examined for this analysis, the first mention of the 
Danish researchers' letter on mammography screening in The Lancet was 
published in The Washington Post. On October 19, 2001, the day before Olsen 
and G0tzsche's review came out, The Post published an article entitled 
"Analysis: Mammograms Don't Cut Cancer Death Risk; Danish Researchers Find 
No Reliable Evidence in Major Studies to Support Medical Consensus" (Okie 
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2001 ). This article reported that the review stated that there was no reliable 
evidence that mammography reduced the risk of dying from breast cancer, but 
the coverage was not picked up in the other major newspapers or any of the 
television news sources examined in this analysis until December. This was not 
altogether surprising since these same researchers had previously published an 
analysis questioning the value of mammography in 2000 which had stated that, 
"There is no reliable evidence that screening decreases breast cancer mortality", 
similar to the message of their 2001 letter (G0tzsche and Olsen 2000). However 
there had been very little coverage of it then. Possibly because the Lancet 
critique published with the 2000 article had questioned the researchers' 
reasoning, methods and results, unlike the commentary published with the 
research letter in 2001 that strongly supported the findings (de Koning HJ 2000). 
It could have also been that in 2000 no one picked up on the story and gave it 
prominent coverage. 
The One that Got Things Started 
Olsen and G0tzsche's second study of mammography may have 
generated a similar lack of interest if it were not for the coverage instigated by 
The New York Times in early December. After Gina Kolata's article on the front 
page of The New York Times (NYT) on December 91h, newspapers and television 
news from across the country started to pick up the story and run their own 
pieces about the mammography debate. From the publication of the original 
research letter in October to the follow-up research letter opposing the findings in 
The Lancet in March there were 33 articles in major newspapers, 16 newspaper 
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editorials or commentaries and 24 television news stories, and all but the 
October Post article were published or broadcast after the NYT article on 
December 9, 2001. Several experts have commented that without Ms. Kolata's 
coverage there would have been no debate over mammography. It may have 
been the tone of the article or its' prominent placement on the front page of one 
of the countries leading papers. However her coverage was noticed and thus 
other reporters followed with their own stories. The content of some of the 
articles and stories published in December, including Ms. Kolata's first article, 
about mammography are detailed here. 
The first article in the NYT reported that the study by Olsen and G0tzsche 
had stirred passionate debate both in Europe and the U.S. with their conclusion I 
that screening mammograms don't prevent breast cancer deaths. The Kolata 
article contained quotes from the Danish researchers and also contained 
information from supporters of mammography from the National Institutes of 
Health and the American Cancer Society. She also outlined the analysis 
conducted by the Danes and how it challenged the usefulness of mammography 
(Kolata 2001a). That same day on the ABC's World News Tonight Sunday 
reporter Bill Blakemore reported on the controversy over mammography. In the 
report, Blakemore interviews Dr. G0tzsche who states that while they think that 
mammography is useful when a lump is suspected, inviting a healthy population 
for screening is another matter (Blakemore 2001). Also in the interview, another 
scientist, Dr. Lerner, and a breast cancer advocate, Ms. Christine Brunswick of 
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the National Breast Cancer Coalition, both emphasized the benefits of 
mammography have tended to be exaggerated to women (Blakemore 2001 ). 
The following morning on ABC's World News This Morning, CNN's 
Morning with Paula Zahn and NBC's Today show there were reports on the 
effectiveness of mammography and the conclusions of the Danish researchers 
(Berman 2001, Zahn and Cohen 2001, Couric 2001 ). An example of the 
importance of the NYT article is that on the Today Show they even stated that 
they were following up on the front-page story published in the NYTthe day 
before (Couric 2001 ). 
Coverage for the rest of the weeks in December was fairly limited. See 
Appendix A for a chart of the coverage by week and source. An article from the 
Seattle Times published at the end of December, reported that despite the 
debate the message from Seattle medical experts to women was to get a 
mammogram and then keep getting them. Many scientists did concede that 
mammography is not a perfect screening tool, but that the Danes review was 
methodologically flawed and therefore their conclusions about mammography 
were not as clear as stated (Blake 2002). Abigail Trafford wrote an impassioned 
article for the Washington Post which highlights why the simple statement that 
screening mammography does not save lives was so inflammatory to so many. 
She writes that many advocates and doctors hold up the idea that mammography 
saves lives as a "sacred dogma" and that "pink ribbon" fundamentalists are quick 
to brand those opposed to mammography as heretics (Trafford 2001 ). This helps 
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to explain how emotionally charged people got about the mammography debate 
in the next few months. 
The Physician Data Query (the PDQ) Weighs In (January 2002) 
In January 2002, the PDQ stated that while they agreed with portions of 
Olsen and G0tzsche's review they had reservations about other portions of it. 
They were only changing their recommendations about screening mammography 
to reflect other doubts the committee had about the evidence for mammography 
and about the value of screening mammography (Mclellan 2002). 
The PDQ 
An independent advisory board to the NCI, the Physician Data Query 
Screening and Prevention Board (the PDQ) reviewed the evidence on screening 
mammography after the Cochrane review was published. The PDQ is 
responsible for the maintenance and accuracy of the PDQ summaries that 
appear on the NCI website (PDQ 2002). In this case the PDQ Screening and 
Prevention Editorial Board reviews the information about mammography 
screening. The board reviews the literature about screening on a regular basis 
and conveys their information to lay people and health professionals on the 
Website. They do not make official recommendations for the NCI. 
National Cancer Institute (NCI)/Nationallnstitutes of Health (NIH) 
The National Cancer Institute (NCI) is in a position of having to provide 
recommendations about cancer screening services based on the best scientific 
evidence available. Their recommendations are read and followed by health 
professionals and are currently used to make cases for covering women with 
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private insurance, Medicare and Medicaid. While the NCI is advised by the PDQ, 
they do not necessarily change their recommendations based on the findings of 
the PDQ. 
Media Coverage 
After the Physician Data Query Board (PDQ) issued their views on 
screening mammography there was a new flurry of news articles and TV news 
reports. Three articles in the NYT, one in The Boston Globe and one in The Los 
Angeles Times reported that the PDQ had concluded that they could no longer 
conclusively state that mammography prevented deaths from breast cancer 
Board was interviewed for several pieces and stated in the L.A. Times that while 
I 
I 
(Kolata 2002b, Kalata 2002c, Kalata 2002d, Foreman 2002, Maugh 2002). Dr. 
Donald A. Berry of the M.D. Anderson Cancer Center and member of the PDQ 
mammography may turn out to be beneficial that the current benefit was not 
spectacular (Maugh 2002). On American Morning with Paula Zahn on CNN, they 
discussed if mammograms are ineffective. Zahn and medical correspondent, Dr. 
Sanjay Gupta, talked about the conclusions of the PDQ that challenged the 
usefulness of mammography for women in the general population and how the 
NCI had not changed their recommendations despite that. They also talked about 
what the Cochrane analysis really showed and the controversy surrounding the 
issues (Zahn and Gupta 2002). An article in The Boston Globe, "Mammogram 
Studies Leave Future Unclear", stated that the job of the PDQ was to sort out 
complicated data and to put their findings on their website. The article reported 
that the PDQ panel had concurred with the Danish researchers that there was 
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insufficient evidence to recommend mammography (Foreman 2002). The PDQ 
conclusions continued to be mentioned and contrasted with later developments 
over the next few months (ex. Kalata 2002 d, Stolberg 2002 a). When the PDQ 
statements stirred the debate, other medical organizations quickly reacted. 
The Big Ad in the New York Times (January 31, 2002) 
The next major development was the publishing of a full-pagead in The 
New York Times advising women to continue to have mammograms (See the full 
text of the letter in Appendix B and Kalata 2002 c). This ad was signed by 10 
major cancer organizations including the American Academy of Family 
Physicians and the American Cancer Society. Four days later a letter to the 
editor, also in the NYT, strongly urged all women to listen to their physicians and 
obtain mammograms according to the current guidelines and was co-signed by 
191eading cancer organizations (Norton 2002). 
Media Coverage 
John McKenzie, on World News Tonight (ABC) on February 1, 2001, 
reported on the conflicting information regarding mammography. He talked 
about the full-page ad in The New York Times supporting mammography which 
was paid for by the 10 organizations. He featured the quote from the ad that 
stated, "While the existing studies of mammography screening have known 
limitations and even some flaws, the evidence as a whole solidly supports 
mammography screening." On February 2, on Saturday Today on NBC, the full-
page ad was also mentioned that was urging women not to abandon 
mammograms (O'Brian and Bloom 2002). On Page One of the Los Angeles 
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Times on February 1 •t, the lead sentence said that women should continue to get 
regular screening according to several national medical organizations, 
referencing the ad (Maugh 2002). The NYT mentioned in its article, "Dispute 
Builds Over Value of Mammography" that the ad had mentioned that the 
organizations were concerned that the public debates were eroding the public's 
faith in mammography (Kalata 2002). They also reported that the Lancet had just 
published a new analysis supporting mammography. This was part of the next 
big event in the timeline. 
The NCI and The Lancet Weigh In (January 31, 2002) 
The National Cancer Institute released a statement on January 31, 2002 
(Updated on 2/21/02) that after due consideration that they continued to 
recommend screening for women aged 40 and older with special consideration 
for women at high risk (NCI Press Release 2002). With this announcement it 
was clear that the NCI was choosing to ignore the recommendations of the PDQ, 
which is solely an advisory committee to the NCI, and were recommending the 
following. 
1. Women in aged 40 to 49 should be screened every one to two years with 
mammography. 
2. Women aged 50 and older should be screened every one to two years. 
3. Women who are at higher than average risk of breast cancer should seek 
expert medical advice about whether they should begin screening before age 40 
and the frequency of screening. 
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Scientific Literature Coverage 
In the February 2, 2002 issue of The Lancet there was a news piece about 
the Physician Data Query (PDQ), the independent expert panel sponsored by the 
National Cancer Institute (Mclellan 2002). This piece reported that the PDQ ad 
reassessed the evidence on mammography and changed their recommendations 
on their website to reflect the greater uncertainty about screening 
mammography. Additionally in the correspondence section of this issue, 
"Screening mammography: setting the record straight" the controversy focused 
on the publishing two versions of the Cochrane review- the one in The Lancet 
and they one sanctioned by the Cochrane reviewers on their website - and the 
resulting conflicts (CBCG editors 2002, Langhorne 2002, G0tzsche 2002, Horton 
2002, Goodare et al. 2002). There was also an original research letter in this 
issue "Mammographic screening: no reliable supporting evidence?" where a 
group of researchers using a different, and according to them more appropriate 
mortality-related measure, found that there was reliable evidence of mortality 
reduction due to screening (Miettinen et al. 2002). 
Media Coverage 
Both the statement by the NCI and the article by the Lancet were covered 
by the press. They were both mentioned in a report on ABC World News Tonight 
as supporting mammography (McKenzie and Johnson 2002). On American 
Morning with Paula Zahn and on CNN Live both airing on February 1, 2002, the 
same story was run about the mammography controversy and in it the medical 
correspondent (Dr. Gupta) stated that the NCI had been all over the controversy 
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from the beginning and were still recommending mammography for women 40 
and over (Hemmer and Gupta (a, b) 2002). The NBC Nightly News began their 
report on mammography by stating that there had been absolutely no change in 
NCI's recommendations (Bazell 2002). On the CBS Evening News, Dr. Peter 
Greenwald of the National Cancer Institute stated that despite the PDQ's report 
the NCI's guidelines supporting mammography would not change (Assuras 
2002). They also interviewed one of the authors of the piece published in the 
Lancet, Dr. Claudia Henschke of New York Weill Cornell Medical Center, stated 
that the reliable evidence of mammography saving lives is in the later years of 
follow-up as shown in their analysis (Assuras 2002). There was also coverage of 
2002 and Kalata 2002 e). 
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the Lancet article and the NCI statement in the NYT and the LA Times (Maugh 
The US Department of Health and Human Services Presents Their 
Recommendations (February 21, 2002) 
In a news conference on February 21, 2002 the official voice for the US 
government on the mammography matter, the United States Department of 
Health and Human Services presented their recommendations in a large press 
conference in Washington, D.C. The Department of Health and Human Services 
reported the United States Preventive Services recommendations as the ones 
they endorse for guiding the use of screening mammography (US DHHS Press 
Office 2002). The Director of the U.S. Department of Health and Human 
Services, Tommy Thompson, held a press conference to present the 
recommendations of the government (Vendantam 2002). The recommendations 
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were based on the two-year evaluation of the evidence conducted by the U.S. 
Preventive Setvices Task Force (USPSTF), an independent group of scientists 
that publishes the Guide to Clinical Preventive Setvices (US DHHS Press Office 
2002). 
U.S. Department of Health and Human Setvices Secretary Tommy G. 
Thompson presented the governments recommendations for mammography. In 
the news conference Secretary Thompson made the following statement-
"The federal government makes a clear recommendation to women on 
mammography: If you are 40 or older, get screened for breast cancer with 
mammography every one to two years". 
-Tommy G. Thompson (NYT- Excerpt 2002) 
The Department supports the recommendations of both the USPSTF and 
the NCI. On a personal note, he also revealed that his wife was a breast cancer 
sutvivor and that she believes that mammography screening may have saved 
her life (US DHHS Press Office 2002). The recommendations presented by 
Secretary Thompson came from the United States Preventive Setvices Task 
Force. 
United States Preventive Setvices Task Force (USPSTF) 
The USPSTF produces The Guide to Clinical Preventive Setvices that is 
an established reference for health professionals and is updated every few years 
by the task force (USPSTF 1995). The third edition of The Guide is scheduled to 
come out this fall. Partially due to the controversy caused by the debate, they 
released their updated mammography guidelines earlier to be reported by the 
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government (USPSTF 2002). Committees of expert scientists from across the 
country write the recommendations by weighing the evidence from all available 
trials in making their decisions. In second edition, the USPSTF was a supporter 
of breast cancer screening in women aged 50 to 74 and rated the evidence for 
screening as good (USPSTF 1995). In its third edition to be published later this 
year, they extended their screening recommendations to include women in their 
forties but drop their rating of evidence to fair (HHS Press Office 2002). 
Media Coverage 
The government's recommendation was that screening mammograms 
would now be recommended for women every one to two years starting at age 
40 (Vendantam 2002, Stolberg 2002, Garvey 2002). This recommendation 
advised starting at a younger than the previous recommended starting age of 50, 
but while it was not mentioned much in the news conference the quality rating of 
the evidence for screening mammography was reduced from good to fair 
(USPSTF 2002). 
The press conference made the national headlines that night on both the 
ABC and CBS evening newscasts, both stated that Tommy Thompson had 
confirmed the value of mammograms for women over 40 in a press conference 
(Jennings 2002 and Andrews 2002 a). There was also coverage on the CBS, 
NBC, CNN and Fox News morning shows. The CBS Morning News had an 
interview with Secretary Tommy Thompson who reiterated that he felt that, 
"Mammography is an important and effective early detection tool that does help 
to save lives"(Andrews 2002 b). The CBS Early Show featured a longer 
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interview in which he stated that the federal government is clearly recommending 
that if you are over 40 you should have a mammogram every one to two years 
(Clayson 2002). Fox News also interviewed Secretary Thompson for their 
newscast in which he reiterated the government's recommendations. 
The USA Today reported that the USPSTF had stated that there was only 
"fair evidence" that mammograms reduced breast cancer deaths (USA Today 
2002). The article started by restating the common opinion that mammograms 
are sometimes a painful procedure and added that because of the likelihood of 
false positives that mammograms might cause more pain and discomfort than 
benefit. The article also reported that Thompson had intended his announcement 
to "quiet the controversy'' over screening but they gave the opinion that the 
controversy maybe was the needed impetus to get better answers to the 
screening question (USA Today 2002). The Washington Post, stated that the 
recommendation by the Department of Health and Human Services was based 
on a comprehensive two-year evaluation by the USPSTF and that they were 
recommending mammography. The reporter also stated since no new studies 
are coming and experts continue to disagree that the DHHS's recommendations 
may not settle the debate (Vedantam 2002). The NYT ran excerpts from 
Secretary Thompson's speech and had an article on the new guidelines and 
previous controversy (Stolberg 2002 b). There were numerous other articles and 
editorials and this event marked the greatest coverage of the mammography 
debate in the period studied. 
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The Senate Hearings (February 28, 2002) 
On February 28, 2002 Senators Tom Harkin (D- Iowa) and Barbara A. 
Mikulski (D- Maryland) co-chaired a US Senate subcommittee hearing entitled 
"Making Sense of the Mammography Controversy: What Women Need to Know" 
on February 28, 2002. According to Senator Mikulski's office, this hearing was 
prompted by the recent Cochrane review on mammography and the resultant 
media coverage that had questioned the value of screening mammography 
(Mikulski Press Release 2002). The hearing was a joint hearing of the Senate 
Committee on Health, Education, Labor and Pensions' Public Health 
Subcommittee and the Senate Committee on Appropriations Subcommittee on 
Labor, Health, Human Services and Education (See Table 4 for Senators 
Attending). 
Table 4. Senators Speaking at the Joint Hearing on the Mammography 
Controversy (Making Sense of the Mammography Controversy 2002) 
U.S. Senate Health, Education, Labor U.S. Senate Appropriations 
and Pensions Committee: Public Health Committee: Subcommittee on Labor, 
Subcommittee Health and Human Services, 
Education 
Edward M. Kennedy (Chairman, D-MA), Tom Harkin (Chairman, D-IA), 
Tom Harkin (D-IA), Barbara A. Mikulski Ernest F. Hollings (D-SC), Daniel K. 
(D-MD), James Jeffords (1-VT), Jeff Inouye (D-HI), Harry Reid (D-NV), 
Bingaman (D-NM), Paul David Wellstone Herb Kohl (O-Wl), Patty Murray (D-
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(D-MN), Jack Reed (D-RI), John WA), Mary Landrieu (D-CA) 
Edwards (D-NC), Hillary Rodham Clinton 
(D-NY) 
William Frist (Ranking Member, R- TN), Arlen Specter (Ranking Member, R-
Judd Gregg (R-NH), Mike Enzi (R-WY), PA), Thad Cochran (R-MS), Judd 
Tim Hutchinson (R-AR), Pat Roberts (R- Gregg (R-NH), Larry Craig (R-ID), 
KS), Susan Collins (R-ME), Jeff Kay Bailey Hutchison (R-TX), Ted 
Sessions (R-AL), Christopher Bond (R- Stevens (R-AK), Mike Dewine (R-OH) 
MO) 
Witnesses at the hearing included both scientists, persons from the medical 
community and breast cancer advocates. Andrew Von Eschenbach, the new 
Director of the National Cancer Institute testified at the hearing reassured the 
women of the nation that the NCI still recommends that women begin 
mammographic screening in their 40s to encourage trends in increasing survival 
seen in the last decade (Congressional Record 2002). A member of the PDQ 
Board, Dr. Donald Berry also testified to the Senate, he stated that women 
should be told the truth about screening. They need to be told that the benefits 
and risks of mammography are uncertain and that they should be informed of 
these benefits and risks and decide about screening for themselves 
(Congressional Record 2002). 
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Media Coverage 
The New York Times was the only newspaper in this study that reported 
on the Senate hearings and stated that after the Senators heard from both 
opponents and supporters of mammography the Senate members "pointedly 
threw their support behind breast cancer screenings" (Stolberg 2002 c). 
According to the article the senators were often outright ignoring the testimony of 
experts contending that mammograms may not be an ideal tool (Stolberg 2002 
c). Good Morning America on ABC was the only television news program to 
report on mammography on the day of the hearings and their reporter, Dr. Tim 
Johnson, attempted to clarify the issues and offer reassurance. He made the 
important distinction that diagnostic mammography had never been in question; it 
was screening mammography that had been debated. He stated that the debate 
was about whether or not finding these breast cancers at earlier stages saves 
lives (Johnson 2002). 
The Medical Research Community Gets the Last Word- For Now (March 
2002) 
The final major event in this debate was the publishing of a new review of 
the Swedish mammography trials in The Lancet. Conducted by the Swedish 
clinical trials researchers, the new analysis (another round of statistical analysis 
of existing trials), stated that women who get mammograms regularly are 21 
percent less likely to die from breast cancer and that screening mammograms 
are especially useful for women over the age of 55 (Smith 2002). In it the group 
of Swedish researchers presented results of their updated overview of the four 
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( Swedish randomized trials. They found that a significant reduction in breast 
cancer mortality was achieved for women aged 55-69 at the start of screening 
(Nystrom et al. 2002). The accompanying commentary by Gelman and Olivotto 
entitled "The mammography screening debate: time to move on" specifically 
addressed the need for clear information for journalists and the potential 
confusion that has been created by recent controversy (2002). These strong 
supportive findings for breast cancer screening were reported in The Washington 
Post and The Boston Globe, and seemed to bring to a conclusion some of the 
mammography debate for now (Okie 2002, Smith 2002). 
The Role of Editorials Throughout the Debate 
The mammography controversy produced many editorials, and because 
they did not have to reflect a balanced view of the issue they were some of the 
most colorful writing about the debate. They also represented the opinions of a 
wide variety of people including breast cancer doctors and breast cancer 
survivors. It reveals the emotions of the people involved and reflects emotional 
investments rather than careful reporting of facts. Some of the editorials were by 
the editorial staff at the newspapers and some were commentaries by leaders in 
the mammography field. The editorials were often the most inflammatory and 
presented strong arguments for and against mammography. While I can't detail 
all of them in this paper due to their number, all of the editorials published by 
these newspapers during this time period and examined for this analysis are 
listed by title in Appendix C under the newspaper editorials section. Some of the 
more interesting ones are mentioned here. I did not include the letters to the 
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editor that were often the most passionate treatises about the issue because of 
their large number and erratic length and quality of writing. I also felt they would 
carry less weight with the public than editorials or articles that were reviewed and 
edited by the news professionals. 
For example, an opinion statement in The Seattle Times stated in mid-
December that, "In the final analysis, a statistical study doesn't mean much to a 
woman whose breast cancer was caught in time because of a mammogram" 
(Mammograms: Should we ... 2001 ). This brings up an important issue in the 
content of both articles and editorials; while most mentioned the published 
research the anecdotal evidence from individual women and physicians is often 
used as a counter argument as to why mammography works. This is a significant 
difference from scientific articles that can't use anecdotal experiences to support 
a point. Ellen Goodman of The Boston Globe writing as a member of a high-risk 
group, women with a family history of breast cancer, made two important points 
from the standpoint of the mammography consumer. The first was that while the 
research on mammography is done on thousands of patients, women have to 
make hard decisions one by one. The second was that women are looking for a 
cure for breast cancer and need less confusion over what they should do now 
about detecting it early (Goodman 2001 ). 
Dr. Daniel B. Kopans, the director of breast imaging at Massachusetts 
General Hospital in Boston and a professor of radiology at Harvard Medical 
School lambasted both The Lancet and The New York Times for their coverage 
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of the mammography issue. His opening paragraph was in all caps and made 
this statement (Kopans 2002). 
IN OCTOBER THE MEDICAL JOURNAL LANCET IRRESPONSIBLY 
PUBLISHED A LETIER THAT CALLED INTO QUESTION WHETHER 
MAMMOGRAPHIC SCREENING COULD SAVE LIVES. IGNORED BY 
MOST PHYSICIANS AND SCIENTISTS, THE LETIER WAS GIVEN 
CREDENCE TWO MONTHS LATER BY AN UNCONSCIONABLE 
FRONT-PAGE ARTICLE IN THE NEW YORK TIMES, HIGHLIGHTING 
ITS CONCLUSIONS. LIKE A STONE DROPPED INTO THE WATER, 
WAVES OF CONFUSIONS SPREAD FROM THE ARTICLES. 
-Daniel B. Kopans 
Kopans' editorial sharply criticized the Danish researchers Cochrane 
review and encouraged women to continue to have mammography. I. Craig 
Henderson, vice chairman of the National Academy of Sciences Institute of 
Medicine committee that studied the early detection of breast cancer stated in his 
editorial in the NYTthat regular mammograms remain an important tool even 
though they are not perfect (Henderson 2002). The following week again in the 
NYT, Virginia L. Ernster, a professor of Epidemiology at the University of 
California - San Francisco, editorialized that mammography is a personal choice 
that needs to be made individually carefully weighing the benefits of 
mammography against the uncertainties and frequency of false positives (Ernster 
2002). Another editorial called the controversy over mammography "absurd" 
(Kinsley 2002). Barron Lerner, author of "The Breast Cancer Wars", attempted in 
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his editorial in The Washington Post to clarify many of the important issues of the 
debate. His editorial was unique in that it included the problems for physicians 
that arise when evidence-based medicine contradicts their own clinical-judgment 
(Lerner 2002). He also highlighted that despite the current focus in modern 
medicine on patient autonomy that physicians still feel uncomfortable letting 
patients make their own decisions (Lerner 2002). Lerner also brought up an 
important point not seen in any other articles or editorials that by questioning 
mammography and thus early detection, we "potentially weaken one of the core 
concepts that has kept this coalition of activists, survivors and politicians 
successful" referring to the highly active breast cancer advocacy community who 
tend to advocate strongly for mammography (Lerner 2002). 
The final editorial mentioned here is one by Barbara A. Brenner, the 
executive director of Breast Cancer Action, an advocacy group much like those 
described by Lerner. However contrary to Lerner's opinion that advocacy groups 
need the mammography issue, she states that the current debate is "drowning 
out other important discussion". Meaning that there is an important need to 
move beyond mammography to make progress in breast cancer survival 
(Brenner 2002). 
What the Public Heard (February- March 2002) 
Unfortunately there is limited information about what the public took from 
the coverage of the mammography debate. The only source was a poll of 1003 
adults conducted by the Kaiser Family Foundation and the Harvard School of 
Public Health (2002) that found that nearly half of all adults reported closely 
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following the ongoing stories about screening mammography during the time 
period from February 25 to March 25, 2002. Not surprisingly more women than 
men reported following the discussion closely during this time period (64% vs. 
27%). Interestingly fewer people could identify the topic of the recent debate. 
When asked the question, "Thinking about what you have seen or heard in the 
news recently about mammograms, what was the recent debate about?" they 
could respond in one of three ways. Thirty-six percent answered that it 
concerned the introduction of a better breast cancer-screening test, 37% 
responded that they didn't know and only 27% correctly answered that the 
debate was about whether or not mammograms have been proven to save lives 
(Kaiser Family Foundation 2002). While more women followed the discussion, 
approximately equal numbers of men and women knew that it was about whether 
or not screening mammography saved lives (Kaiser Family Foundation 2002). 
Advocacy groups -The American Cancer Society and The National Breast 
Cancer Coalition 
The American Cancer Society 
These recommendations are virtually identical to those put out by the 
American Cancer Society and other organizations in recent years (ACS 2002). 
The ACS is the largest community-based health organization dedicated to 
preventing cancer occurrence, suffering and death. Dr. Harmon Eyre, Chief 
Medical Officer of the ACS stated that the ACS agreed with the U.S. Preventive 
Services Task Force that the scientific evidence behind mammography is strong 
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enough to recommend screening mammography for all women (Making Sense 
2002). 
National Breast Cancer Coalition 
Among those opposing the idea that mammography was a good screening 
tool was the National Breast Cancer Coalition, a consumer advocacy group 
headed up by Fran Visco (NBCC 2002). Visco stated in an interview for an 
article in The Washington Post that this simplification and seemingly lock step 
stance of major cancer players about mammography greatly underestimated a 
woman's ability to weigh the evidence and understand the pros and cons. The 
article concludes with the opinion that this "get-a-mammogram-no-matter-what-
you-hear recommendation sounds more like faith-based health policy than 
evidence-based medicine", a good summary to the U.S. government stance 
(Trafford 2002). 
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Conclusions and Public Health Implications 
On February 11th of 2002, Gina Kolata and Michael Moss wrote an article 
that was published in The New York Times that summarized the debate about 
screening mammography. In their article they detail how that for decades 
mammography had simply been assumed to the best way to reduce breast 
cancer mortality and that now it was the "focus of a bitter and unusually public 
scientific dispute that is being fought in the pages of medical journals and the 
columns of daily newspapers" (Moss and Kolata 2002). 
In this paper I have attempted to illuminate several aspects of the debate 
about mammography that has taken place in the news media, the medical journal 
The Lancet, and some of the major players in the cancer field. It is important to 
realize that many aspects of medical research are often unclear and that debates 
such as this will arise from time to time. What is important is how the media and 
others, such as government agencies and advocacy groups, handle these 
debates. I feel that the role of the media in covering these debates is essential 
since much of the public is not exposed to medical information any other way. In 
the final section of this paper I will attempt to form some recommendations on 
how debates and controversies such as this are handled in the future. First it is 
important to recap certain aspects of the recent mammography controversies. 
Screening Mammography Debate in the Lancet 
The original Cochrane review research letter published by Olsen and 
G0tzsche, the accompanying commentaries about it and the follow-up 
correspondence responding to it illustrate the problems that can result from the 
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secondary analyses of clinical trials. Different researchers using different 
techniques can get different results using the same data sources. This exposes 
one of the great limits of meta-analysis, the scientific community often relies on 
the synthesis and analysis of multiple trials in order to make recommendations to 
the medical community and public. Even reviewers from the prestigious 
Cochrane collaboration produced a review that ended up producing more 
controversy than clarity. 
Another problem that can arise when reviews are used to make 
recommendations is this. Epidemiologists and statisticians look at data from 
clinical trials and other studies and make findings based on the data and not the 
people in the trials. These recommendations come out and often conflict with 
what is currently medical practice. Since physicians often use anecdotal 
evidence from their personal practice to judge the value of a test, their personal 
experience may conflict with the conclusions of the study and therefore they may 
be resistant to change based only on reviewed data. Many of the scientists 
writing in to The Lancet to comment on the review defended their own work and 
questioned why it was discounted by the reviewers, others remarked that use of 
screening mammography finds cancers at smaller sizes and earlier stages, still 
others defended the review as an important wake-up call about the limits of 
mammography. The final article published on mammography was yet another 
review of almost the same data Qust the Swedish trials) showed the opposite 
result of the Cochrane review, but since more people tend to believe that 
mammography works it seemed to appease the current controversy. 
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The Screening Mammography Debate in the News Media 
Coverage of the current screening mammography debate began in 
earnest after an article was published on the front page of The New York Times. 
Even though the original research letter was published in late October it went 
largely unnoticed until The New York Times article. This article in December 
created the first flurry of news coverage about the issue, all of which was 
basically stating that these scientists had shown mammography to be largely 
ineffective in reducing breast cancer mortality and most featured responses by 
irate breast cancer screening advocates declaring that the new analysis must be 
wrong. It was after this coverage in December that the major players such as the 
Physician Data Query and the National Cancer Institute began to review the 
information. 
The Screening Mammography Debate and the Major Players 
The PDQ was the first major player to weigh in on the mammography 
debate and have their recommendations covered by the media. Since they also 
stated that they had some issues about the usefulness of screening 
mammography this made their statements inflammatory to large groups of major 
cancer players. This may have been what sparked 9 major professional medical 
and cancer organizations to place a full-page ad in the New York Times. Even 
this ad sparked its own media coverage with outlets reporting that the 
mammography controversy had grown but that mainstream organizations like the 
American Cancer Society and the American Medical Association were still 
advocating screening. Most likely because of the statements of these 
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organizations that the National Cancer Institute felt it was important to restate 
their position that mammography is still recommended. At the end of February, 
the US Department of Health and Human Services also presented their 
guidelines. They presented the updated recommendations of the US Preventive 
Services task force that recommend mammography for all women over 40 every 
one to two years. This became the official position of the government in regards 
to screening. While this was ostensibly supposed to quiet the debate about the 
mammography issue, several sub-committees of the U.S. Senate held hearings 
after the announcement interviewing some of the major players in the 
mammography and breast cancer field about the original Olsen and G0tzsche 
review and the subsequent recommendations and reports of the PDQ, NCI and 
USPSTF. It is important to realize that while the official and bigger name cancer 
players were holding press conferences and releasing their information, the 
organizations that advise and influence a woman's decision to screen for breast 
cancer, such as the American Cancer Society and National Breast Cancer 
Coalition were also weighing in with recommendations and advice both in the 
news and on their perhaps more importantly on their websites. 
A Brief Caveat on the Role of the Internet 
While Internet coverage was not discussed in this paper, it is important to 
realize its growing influence on the public. More and more people are connecting 
to the Internet every day. More importantly both the media and the Internet play 
a role in informing the general public and current cancer patients about new 
developments in the field. For example, a study evaluating the use of the news 
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media and the Internet as sources of medical information for patients and 
oncologists found that 50% of patients searched the Internet for information and 
that patients were evenly split in their opinions about the balance and accuracy of 
news media reports of medical issues (Chen and Siu 2001 ). 
Other Examples of Public Health/Medical News Coverage 
There were two major medical and public health issues that occurred 
either during the mammography controversy or just after it concluded. These 
were two more examples of how public health interacts with the media and the 
public. Fears about bioterrorism, mainly the use of smallpox and anthrax, had 
the public clamoring for information after 9/11/2001. Recently this has led to a 
debate, which has been fueled by media coverage, of who should be vaccinated 
for smallpox and when. Also recently there were new concerns over the use of 
hormone replacement therapy when the largest trial studying the use of the drugs 
found that use of both estrogen and progesterone increased risks of strokes and 
breast cancer (NIH Press Office 2002). Both of these issues were covered 
heavily by the press and were important to the general public. 
Final Comments on Screening Mammography 
It is impractical and unlikely that another randomized trial of 
mammography will ever be undertaken. We as a society would never consent to 
a randomization that had one arm of the trial having women receive no 
screening. So in the case of mammography, we will have to live with a certain 
degree of uncertainty. What medical professionals need to do is to inform their 
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patients more fully about the benefits and risks when making their 
recommendations about any type of screening test. 
Lessons that can be learned and applied to other public health and medical 
controversies 
The public and the media could learn several important things from how 
the debate was presented in the literature, covered by the news media and 
responded to by the major players. 
1. Scientists often disagree about the results of a study and that when 
reanalysis of data is done sometime the results are different. 
It is important to keep in mind the methodology of the review and the way it was 
published. Peer-reviewed published research is the best way to ensure that the 
study was rigorously conducted and has valid results. 
2. It is important for both the media and the public to keep in mind the 
context of review and who wrote it in determining its value in deciding a 
complicated question such as mammography. 
3. The public needs to look at who are the "experts" that are quoted or 
interviewed by reporters. 
For example, do their work affiliations indicate that they may have some bias 
about the issue and have they carefully reviewed all the scientific evidence 
before coming to their conclusions? 
4. What the scientific community discusses about an issue isn't necessarily 
what the media reports on. 
5. What the media reports on isn't necessarily what the public hears. 
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This was evidenced by the Kaiser Family Foundation survey showing that most 
people thought the debate was about mammography technology, not use. 
6. This debate was an excellent example of what happens when major 
players (government agencies, advocacy groups, review boards) don't 
coordinate to decide in private what the message about a subject will be. 
In this case and in many others these groups issued recommendations 
piecemeal, which could potentially confuse the public and may frustrate them in 
their attempts to be informed consumers. 
7. A Need for Mutual Respect between the Media and the Medical/Public 
Health Community 
There is a growing need for reporters to be trained to deal with the scientific 
literature and researchers. There is also a need to educate both researchers and 
major players on how to deal with the media in order to get the clearest 
messages out to the public. Their needs to be a mutual respect built between 
these entities so that controversies such as this are presented more clearly to the 
public. In the future we need to build better communication between the scientific 
community, media, major players and most importantly the public so that 
important research information is diffused in the most efficient manner. 
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Appendix A: Table of Dates of Coverage and Sources 
Television News Coverage 
ABC CBS CNN Fox News NBC Total 
1 0/14-10/20 
10/21-10/27 
10/28-11/3 
11/4-11/10 
11/11-11/17 
11/18-11/24 
11/25-12/1 
12/2-12/8 
12/9-12/15 2 1 1 4 
12/16-12/22 
12/23··12/29 
12/30-1/5 
1/6-1/12 1 1 
1/13-1/19 
1/20-1/26 1 i 
1/27-2/2 1 1 2 2 6 
2/3-2/9 
2/10-2/16 
2/17-2/23 1 4 3 1 1 10 
2/24-3/2 1 1 
3/3-3/9 
3/10-3/16 1 1 
3/17-3/23 
3/24-3/30 
Total 5 5 8 1 5 24 
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Major Newspapers 
USA 
10/14-1 0/20 Boston LA Times NYT Seattle Today Post 
10/21-10/27 1 
10/28-11/3 
11/4-11/10 
11111-11/17 
11/18-11/24 
11/25-12/1 
12/2-12/8 
12/9-12/15 
12/16-12/22 1 (1) 1) 
12/23-12/29 1) 1 
12/30-1/5 1 
1/6-1112 1) 
1/13-1/19 1 
1/20-1/26 
1/27-2/2 2 
2/3-2/9 1 1 2(1) 1) 
2/10-2/16 5(2) 1) 2 
2/17-2/23 1) 1) 
2/24-3/2 1 2 2(1) 
3/3-3/9 1) 2(1) 1 1 
3/10-3/16 1 1 1 ( 1) 
3/17-3/23 2 1 
3/24-3/30 1) 
Total 2(2) 3(3) 17(6) 1(3) 1 9(2) 
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Appendix B: Text of the Full Page Ad Supporting Screening Mammography 
from The New York Times 
2002/01/31 -We, the undersigned, representing a broad spectrum of concerned 
health organizations, are responding to coverage in the media and the resulting 
public discussion questioning the value of mammography. This discussion has 
been stimulated by a recent report published in the British medical journal, The 
Lancet, which concluded there was no scientific support for breast cancer 
screening with mammography. 
Women and their healthcare professionals should know that numerous 
independent expert groups in the U.S. and Europe have repeatedly subjected the 
world's major clinical studies of mammography to careful scientific scrutiny, and 
also have carefully evaluated the analysis published in The Lancet. While the 
existing studies of mammography screening have known limitations and even 
some flaws, the evidence as a whole solidly supports reduced breast cancer 
mortality rates due to mammography screening. Early breast cancer detection 
means a greater chance for successful treatment and a greater range of 
treatment options. 
We have grave concerns that these public debates have already begun to erode 
the confidence in mammography that has been built up over the past two 
decades. While mammography is not a perfect tool, it is effective and has 
contributed significantly to the declines in breast cancer mortality since 1990. In 
fact, there will be many thousands fewer breast cancer deaths among U.S. 
women this year due to the combined progress we've made in early detection 
and improved therapy. If women are dissuaded from getting regular 
mammograms, lives will be lost. 
We strongly urge women to continue to follow the advice of their physicians and 
the leading medical organizations. Our organizations will continue to monitor new 
scientific research in order to offer the best advice to women and their 
physicians. 
This letter is cosigned by the following organizations: 
American Academy of Family Physicians, American Cancer Society, American 
College of Physicians, American Society of Internal Medicine, American College 
of Obstetricians and Gynecologists, American College of Preventive Medicine, 
American Medical Association, Cancer Research Foundation of America, 
National Medical Association, Oncology Nursing Society, Society of Gynecologic 
Oncologists 
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Appendix C: Full Listing of Materials from The Lancet Related to the Debate 
[In Chronological Order] 
Olsen 0 and G0tzsche PC. Cochrane review on screening for breast cancer 
with mammography. The Lancet. Vol. 358, pg. 1340-1342. October 20, 2001. 
Horton R. Screening mammography- an overview revisited. The Lancet. Vol. 
358, pg. 1284. October 20, 2001. 
G0tzsche PC. Author's reply: Screening for breast cancer with mammography. 
The Lancet. Vol. 358, pg. 2167-2168. December 22, 2001. 
Dixon-Woods M, Baum M, Kurinczuk JJ. Screening for breast cancer with 
mammography. The Lancet. Vol. 358, pg. 2166-2167. December 22, 2001. 
Vaidya JS. Screening for breast cancer with mammography. The Lancet. Vol. 
358, pg. 2166. December 22, 2001. 
Duffy SW, Tabar L, Smith RA. Screening for breast cancer with mammography. 
The Lancet. Vol. 358, pg. 2166. December 22, 2001. 
Thornton H. Screening for breast cancer with mammography. The Lancet. Vol. 
358, pg. 2165. December 22, 2001. 
Senn S. Screening for breast cancer with mammography. The Lancet. Vol. 358, 
pg. 2165. December 22, 2001. 
Lee JH, Zuckerman D. Screening for breast cancer with mammography. The 
Lancet. Vol. 358, pg. 2164-2165. December 22, 2001. 
McLellan F. News -·Independent US panel fans debate on mammography. The 
Lancet. Vol. 359, pg. 409. February 2, 2002 
Goodare H, Dimmer C, Page K. Screening mammography: setting the record 
straight. The Lancet. Vol. 359, pg. 442. February 2, 2002. 
Horton R. Screening mammography: setting the record straight. The Lancet. 
Vol. 359, pg. 441-442. February 2, 2002. 
Gotzsche PC. Screening mammography: setting the record straight. The 
Lancet. Vol. 359, pg. 440-441. February 2, 2002. 
The CBCG editors. Screening mammography: setting the record straight. The 
Lancet. Vol. 359, pg. 442. February 2, 2002. 
65 Randolph 
Miettinen OS, Henschke Cl, Pasmantier MW, Smith JP, Libby OM, Yankelevitz 
OF. Mammographic screening: no reliable supporting evidence? The Lancet. 
Vol. 359, pg. 404-406. February 2, 2002. 
Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. 
Long-term effects of mammography screening: updated overview of the Swedish 
randomized trials. The Lancet. Vol. 359: pg. 909-919. March 16, 2002. 
Gelman KA, Olivotto I. The mammography screening debate: time to move on. 
The Lancet. Vol. 359, pg. 904-905. February 2, 2002. 
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Appendix D: Full Listing of Articles and Editorials About the Debate [In 
Chronological Order] 
Okie, S. (2001, October 19). Analysis: Mammograms don't cut cancer death risk; 
Danish researchers find no reliable evidence in major studies to support medical 
consensus. The Washington Post, pp. A02. (848 words) 
Kalata, G. (2001, December 9). Study sets off debate over mammograms' value. 
The New York Times, pp.1A. (1950 words) 
The latest mammography debate [Editorial Desk]. (2001, December 1 0). The 
New York Times, pp. 20A. (478 words) 
Mammograms: Should we or shouldn't we? [Opinion]. (2001, December 14): 
The Seattle Times, pp. 86. (405 words) 
Goodman, E. (2001, December 16). Healthy doubts about mammograms [Op-
Ed]. The Boston Globe, pp. D7. (770 words) 
Lewin, T. (2001, December 17). Conflicting breast cancer studies creating 
unsettling uncertainties. The New York Times, pp. 1A. (1467 words) 
Blake, J. (2001, Deceber 27). Mammograms' worth put to the test. The Seattle 
Times, pp. A1. (1350 words) 
Kopans, D.B. (2002, January 1 ). Needless confusion over mammograms [Op-
Ed]. The Boston Globe, pp. A19. (891 words) 
Trafford, A. (2002, January 8). Unfriendly fire in the cancer war. The 
Washington Post, pp. F01. (1155 words) 
Kalata, G. (2002, January 24). Expert panel cites doubts on mammogram's 
worth. The New York Times, pp. A16. (998 words) 
A panel casts doubt on mammogram use. (2002, January 24). The New York 
Times, pp. A1. (142 words) 
Kalata, G. (2002, January 27). January 20-26: Health; Mammography review. 
The New York Times, pp. 4-2. (75 words) 
Uncertainty over mammograms [Editorial Desk]. (2002, January 27). The New 
York Times, pp. 4-12. (553 words). 
Foreman, J. (2002, January 29). Mammogram studies leave future unclear. The 
Boston Globe, pp. D1. (1582 words) 
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Maugh, T.H. (2002, February 1 ). New study defends mammograms; Doctors 
lament conflicting signals. Los Angeles Times, pp. A 1. (1 038 words) 
Kolata, G. (2002, February 1 ). Dispute builds over value of mammography. The 
New York Times, pp.A22. (598 words) 
Stoltz, C. (2002, February 5). The mammogram debate: Highlights; Highlights of 
recent research and recommendations. The Washington Post, pp. F07. (979 
words) 
Kritz F.L. (2002, February 5). Small comfort: While experts debate 
mammograms' value, a pad 'softens' the test. The Washington Post, pp. F01. 
(1419 words) 
Some of the many views of mammography. (2002, February 5). The New York 
Times, pp.F3. (720 words) 
Kalata, G. (2002, February 5). Putting mammograms to the test. The New York 
Times, pp. F1. (1 071 words). 
Brody, J.E. (2002, February 5). Personal health; Choosing to have annual 
mammograms. The New York Times, pp. F8. (1159 words) 
Settle mammogram debate [Opinion]. (2002, February 6). The Seattle Times, 
pp. 86. (208 words) 
Circling the mammography wagons [Editorial Desk]. (2002, February 6). The 
New York Times, pp.A20. (580 words) 
Henderson, I. C. (2002, February 9). Regular mammograms remain a crucial tool 
[Editorial Desk]. The New York Times, pp.A19. (632 words) 
Kalata, G. (2002, February 10). The Nation: Second opinion; the painful fact of 
medical uncertainty. The New York Times, Sec.4, pp.5. (981 words) 
Kalata, G. and Moss, M. (2002, February 11 ). X-Ray vision in hindsight: 
Science, politics and the mammogram. The New York Times, pp. A18. (2627 
words) 
Ernster, V.L. (2002, February 14). Mammograms and personal choice [Editorial 
Desk]. The New York Times, pp.A35. (926 words) 
Mammograms and hope [Editorial Pages Desk]. (2002, February 16). Los 
Angeles Times, Sec. 2 pp. 22. (553 words) 
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Connolly, C. (2002, February 17). Mammography review shatters the status quo; 
Doubts about its value alarm many. The Washington Post, pp. A01. (1352 
words) 
Vedantam, S. (2002, February 22). U.S. Continues to recommend 
mammograms. The Washington Post, pp. A01. (864 words) 
Kinsley, M. (2002, February 22). What's the down side?; The absurd controversy 
over mammograms [Editorial]. The Washington Post, pp.A25. (833 words) 
Excerpts from speech on use of mammograms. (2002, February 22). The New 
York Times, pp.A22. (567 words) 
Stolberg, S.G. (2002, February 22). Guidelines by U.S. urge mammograms for 
women at 40. The New York Times, pp.A1. (1162 words) 
Garvey, M. (2002, February 22). U.S. says mammograms help, and that's final. 
Los Angeles Times, pp. A 1. (797 words) 
Stolberg, S.G. (2002, February 24). February 17-23: National; Mammography 
urged. The New York Times, pp.4-2. (84 words) 
Vedantam, S. (2002, February 24). U.S. gives mammograms a strong ... The 
Washington Post, pp. A03. 
Mammograms work [Opinion]. (2002, February 24). The Seattle Times, pp. 86. 
(212 words) 
Epstein, S.S. (2002, February 25). Mammography doesn't come without risk 
[Editorial Pages Desk]. Los Angeles Times, pp. 2-11. (675 words) 
Women get mixed signals. (2002, February 25). USA Today, pp. 13A. (402 
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